Differential procarcinogenic potential of lymphocyte subsets in immune pathogenesis of hepatocellular carcinoma.

被引：0
|
作者：
Nakamoto, Y [1 ]
Suda, T [1 ]
Kaneko, S [1 ]
机构：
[1] Kanazawa Univ, Kanazawa, Ishikawa 920, Japan
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
50
引用
收藏
页码：179A / 179A
页数：1
相关论文
共 50 条
  • [1] Hepatocellular carcinoma. Pathogenesis and multicentricity
    Blum, HE
    Hopt, UT
    CHIRURG, 2003, 74 (08): : 709 - 716
  • [2] Fas ligand-dependent inhibition of immune pathogenesis of hepatocellular carcinoma.
    Nakamoto, Y
    Kaneko, S
    Fan, H
    Chisari, FV
    Kobayashi, K
    Suda, T
    HEPATOLOGY, 2001, 34 (04) : 242A - 242A
  • [3] Immune pathogenesis of hepatocellular carcinoma
    Nakamoto, Y
    Guidotti, LG
    Kuhlen, CV
    Fowler, P
    Chisari, FV
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02): : 341 - 350
  • [4] Serum neutrophil/lymphocyte ratio as a potential predictor of treatment response for immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.
    He, Jian
    Mo, Zhiqiang
    Mai, Qicong
    Chen, Xiaoming
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Associations Between Infiltrating Lymphocyte Subsets and Hepatocellular Carcinoma
    Guo, Cun-Li
    Yang, Hai-Chao
    Yang, Xiu-Hua
    Cheng, Wen
    Dong, Tian-Xiu
    Zhu, Wen-Jing
    Xu, Zheng
    Zhao, Liang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (11) : 5909 - 5913
  • [6] Role of Hippo Kinase Pathway In Pathogenesis of Hepatocellular Carcinoma.
    Wolfe, Andy
    Apte, Udayan
    FASEB JOURNAL, 2009, 23
  • [7] The alterations in peripheral lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in hepatocellular carcinoma
    Xie, Qu
    Hu, Can
    Luo, Cong
    JOURNAL OF CANCER, 2023, 14 (15): : 2946 - 2955
  • [8] Differential gene expression in human hepatocellular carcinoma.
    Du, H
    Sullivan, D
    Gerber, MA
    HEPATOLOGY, 1997, 26 (04) : 1298 - 1298
  • [9] Loss of tyrosine aminotransferase may contribute to the pathogenesis of hepatocellular carcinoma.
    Guan, XY
    Xie, YW
    Sham, JST
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 270 - 270
  • [10] The role of Frizzled 7 expression in the pathogenesis of human hepatocellular carcinoma.
    Merle, P
    de la Monte, S
    Herrmann, M
    Tanaka, S
    Kew, M
    Treppo, C
    Wands, J
    HEPATOLOGY, 2003, 38 (04) : 589A - 589A
12345